B. Lanier et al., STRUCTURAL AND LIGAND RECOGNITION PROPERTIES OF IMIDAZOLINE BINDING-PROTEINS IN TISSUES OF RAT AND RABBIT, Molecular pharmacology, 48(4), 1995, pp. 703-710
Imidazoline/guanidinium receptive sites (IGRS) belong to a family of m
embrane proteins that selectively recognize certain pharmacologically
active compounds with an imidazoline or a guanidinium moiety. The role
of such proteins in the cellular responses elicited by these compound
s is unclear, but two members of this protein family are identical to
isoforms of monoamine oxidase, an enzyme involved in the metabolism of
monoamine neurotransmitters. To characterize the structural and ligan
d recognition properties of the imidazoline binding proteins, we used
the photoaffinity adduct [I-125]iodoazidophenoxymethylimidazoline ([I-
125]AZIPI) to label their ligand binding subunits in selected target t
issues (kidney, pancreatic B cells, liver, and salivary gland). Photoa
ffinity labeling of membrane preparations or subcellular particulate f
ractions from various rat, rabbit, or hamster tissues indicated two la
beled peptides of M(r) similar to 55,000 and similar to 61,000, the re
lative tissue distribution of which mirrored the expression of the A o
r B isoforms of monoamine oxidase. The ligand binding subunit of imida
zoline binding proteins was identified on two peptides of M(r) similar
to 55,000 and similar to 61,000 in rat and rabbit kidney, rat liver,
rabbit salivary gland, and the pancreatic B cell line RIN-5AH, whereas
only an M(r) similar to 61,000 peptide was observed in rat salivary g
land and the hamster pancreatic B cell line HIT-T15. Saturation labeli
ng experiments indicated that [I-125]AZIPI exhibited similar affinity
(K-d similar to 2-3 nM) for both the M(r) similar to 55,000 and simila
r to 61,000 peptides. However, competitive inhibition of photolabeling
indicated that the two peptides were distinguished by their affinity
for the guanidinium guanabenz or their interaction with potassium. Alt
hough some types of imidazoline binding sites are located on the enzym
e monoamine oxidase, the nonisoform selective enzyme inhibitor pargyli
ne did not alter photoaffinity labeling of either the M(r) similar to
55,000 or similar to 61,000 peptide, indicating that imidazolines/guan
idiniums and active site inhibitors of monoamine oxidase interact with
different domains on the enzyme. In rat kidney and liver, an addition
al photolabeled peptide of M(r) similar to 25,000 was observed, and it
s ligand recognition profile was distinct from the M(r) similar to 55,
000 and similar to 61,000 species. In contrast with the mitochondrial
location of the larger peptides, subcellular fractionation of liver ho
mogenates indicated that the M(r) similar to 25,000 localized to the p
lasma membrane.